CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 118.00
+2.50 (2.16%)
Aug 5, 2026, 2:01 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 25.25 billion as of August 5, 2026. Its market cap has increased by 205.30% in one year.
Market Cap
25.25B
Enterprise Value
23.21B
Revenue
1.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
118.00
ChartMarket Cap Chart
Since September 27, 2017, CHO Pharma's market cap has increased from 15.00B to 25.25B, an increase of 68.36%. That is a compound annual growth rate of 6.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 25.25B | 319.93% |
| Dec 31, 2025 | 6.01B | -45.44% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 56.41B |
| Pell Bio-Med Technology | 54.68B |
| Oneness Biotech | 21.79B |
| Sunmax Biotechnology | 20.86B |
| TaiMed Biologics | 15.55B |
| Medigen Vaccine Biologics | 15.40B |
| Ever Supreme Bio Technology | 14.91B |
| Lumosa Therapeutics | 14.57B |